Implications of pharmacogenomics for drug development and clinical practice.

Journal Article (Journal Article;Review)

Pharmacogenomics is likely to be among the first clinical applications of the Human Genome Project and is certain to have an enormous impact on the clinical practice of medicine. Herein, we discuss the potential implications of pharmacogenomics on the drug development process, including drug safety, productivity, market segmentation, market expansion, differentiation, and personalized health care. We also review 3 challenges facing the translation of pharmacogenomics into clinical practice: dependence on information technology, limited health care financing, and the scientific uncertainty surrounding validation of specific applications of the technology. To our knowledge, there is currently no formal agenda to promote and cultivate innovation, to develop progressive information technology, or to obtain the financing that would be required to advance the use of pharmacogenomic technologies in patient care. Although the potential of these technologies is driving change in the development of clinical sciences, it remains to be seen which health care systems level needs will be addressed.

Full Text

Duke Authors

Cited Authors

  • Ginsburg, GS; Konstance, RP; Allsbrook, JS; Schulman, KA

Published Date

  • November 14, 2005

Published In

Volume / Issue

  • 165 / 20

Start / End Page

  • 2331 - 2336

PubMed ID

  • 16287761

International Standard Serial Number (ISSN)

  • 0003-9926

Digital Object Identifier (DOI)

  • 10.1001/archinte.165.20.2331


  • eng

Conference Location

  • United States